TYPHOID VACCINE INACTIVATED (TYPHIM VI)

Course overview

Typhoid vaccine inactivated (TVI) is U.S. FDA-approved to immunize against disease caused by Salmonella typhi (typhoid fever) in persons ≥ 2 years. It must be used cautiously in immunosuppressed patients, and in patients with latex allergy, concurrent anticoagulant therapy, or bleeding disorders. This continuing education module is designed to give the reader/learner an increased understanding of TVI, including its uses, mechanism of action, dosage and administration, drug interactions, contraindications, precautions, and adverse effects. Readers may explore any or all of the topics. One contact hour of continuing education credit is available for those who successfully complete the post-test and evaluation form.